Otonomy, inc. (OTIC)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Product sales, net

600

745

1,236

683

-

-

-

-

Product sales, net

-

-

-

-

0

0

-

-

Costs and operating expenses:
Cost of product sales

912

946

3,098

1,664

-

-

-

-

Cost of product sales

-

-

-

-

0

0

-

-

Research and development

32,805

31,844

42,701

60,723

38,762

31,803

16,336

8,523

Selling, general and administrative

11,690

20,008

46,838

49,777

23,214

-

-

-

General and administrative

-

-

-

-

-

7,836

3,514

2,408

Total costs and operating expenses

-

-

-

-

61,976

39,639

-

-

Total costs and operating expenses

45,407

52,798

92,637

112,164

-

-

-

-

Total operating expenses

-

-

-

-

-

-

19,850

10,931

Loss from operations

-44,807

-52,053

-91,401

-111,481

-61,976

-39,639

-19,850

-10,931

Other income (expense)
Interest income

1,723

1,689

1,271

899

419

105

5

-

Interest expense

1,591

4

0

0

-

-

-

-

Interest expense

-

-

-

-

-

39

2,528

444

Change in fair value of convertible preferred stock warrant liability

-

-

-

-

-

3,300

-2,833

-100

Change in fair value of convertible preferred stock purchase right

-

-

-

-

-

-

-

3,707

Other expense

-

-

-

-1

-111

-4

-19

-1

Total other income, net

132

1,685

1,271

898

308

-3,238

291

3,362

Net loss

-44,675

-50,368

-90,130

-110,583

-61,668

-42,877

-19,559

-7,569

Accretion to redemption value of convertible preferred stock

-

-

-

-

-

35

539

801

Net loss attributable to common stockholders

-

-

-

-

-

-42,912

-20,098

-8,370

Net loss per share, basic and diluted

-1.45

-1.65

-2.97

-3.69

-2.57

-5.46

-268.79

-118.99

Weighted-average shares used to compute net loss per share, basic and diluted

30,726

30,610

30,304

29,962

23,952

7,853

74

70